PAK BioSolutions
Burke, US · Founded 2019 · Delaware corporation · 1 known investors
PAK BioSolutions builds automated systems for end-to-end continuous manufacturing and purification of biopharmaceuticals, sold to biopharmaceutical companies for pilot- and commercial-scale cGMP production. Its equipment supports continuous downstream processing of therapeutic proteins such as monoclonal antibodies.
Founders & leadership

Investors · 1
Reported raises · per SEC filings
Form D private placements$5M disclosed across 2 rounds · 2019–2024
▶$5MraisedJun 2024 · 2 investors · Other TechnologyRule 506(b)
- Joanna PezziniExecutive Officer, Director
- Daniel KidleDirector
- Kevin Hill-ByrneExecutive Officer, Director
- Charles PurtellDirector
- Offering amount
- $8.5M
- Amount sold
- $5M
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$30KraisedJul 2019 · 3 investors · Other TechnologyRule 506(b)
- Pezzini JoannaExecutive Officer
- Kevin Hill-ByrneExecutive Officer
- Offering amount
- $300K
- Amount sold
- $30K
- Proceeds to insiders
- $30.2K
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with PAK BioSolutions for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $325K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does PAK BioSolutions do?
- PAK BioSolutions builds automated systems for end-to-end continuous manufacturing and purification of biopharmaceuticals, sold to biopharmaceutical companies for pilot- and commercial-scale cGMP production. Its equipment supports continuous downstream processing of therapeutic proteins such as monoclonal antibodies.
- Who are PAK BioSolutions's investors?
- PAK BioSolutions's investors include Arboretum Ventures.
- How much funding has PAK BioSolutions raised?
- PAK BioSolutions has disclosed $5M raised across 2 rounds.
- Where is PAK BioSolutions headquartered?
- PAK BioSolutions is headquartered in Burke, US.
